MORC3 and dermatomyositis: For example, anti-MORC3 antibody has been confirmed as one of the major myositis-specific autoantibodies, which are essential in identifying clinically homogeneous subsets and predicting the prognosis of idiopathic inflammatory myopathies (IIMs) (such as polymyositis and DM) [83].